The same applies to employers as well.
While I still have some time, I'm going to ask you my next question.
You referred to illnesses where genomic advancements could help, type 2 diabetes, for example. Is offering people with type 2 diabetes some miracle pill to help their condition really the most effective and smartest approach to the problem? Shouldn't we instead be focusing on other types of prevention such as exercise, physical activity?
I can see the benefit more in the case of rare diseases. When it comes to type 2 diabetes, however, I get the sense that people will just take their genomic drug, thinking that it will keep their chronic illness in check, even if they eat what they shouldn't and don't exercise. I wonder whether that wouldn't send people the wrong message.